ENTRY       D05394                      Drug
NAME        Pegvisomant (USAN/INN);
            Pegvisomant (genetical recombination) (JAN);
            Somavent (TN)
PRODUCT     SOMAVERT (Pharmacia & Upjohn Company LLC)
SEQUENCE    FPTIPLSRLF DNAMLRADRL NQLAFDTYQE FEEAYIPKEQ KYSFLQNPQT SLCFSESIPT
            PSNREETQQK SNLELLRISL LLIQSWLEPV QFLRSVFANS LVYGASDSNV YDLLKDLEEK
            IQTLMGRLED GSPRTGQIFK QTYSKFDTNS HNDDALLKNY GLLYCFNADM SRVSTFLRTV
            QCRSVEGSCG F
  TYPE      Peptide
REMARK      Therapeutic category: 2499
            ATC code: H01AX01
            Product: D05394<JP/US>
EFFICACY    Growth hormone receptor antagonist
  DISEASE   Acromegaly [DS:H01483]
COMMENT     Treatment of acromegaly (competitive inhibition of peripheral growth hormone receptors to block IFG-I production)
TARGET      GHR [HSA:2690] [KO:K05080]
  PATHWAY   hsa04060(2690)  Cytokine-cytokine receptor interaction
            hsa04080(2690)  Neuroactive ligand-receptor interaction
            hsa04151(2690)  PI3K-Akt signaling pathway
            hsa04630(2690)  JAK-STAT signaling pathway
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
               H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
                H01AX Other anterior pituitary lobe hormones and analogues
                 H01AX01 Pegvisomant
                  D05394  Pegvisomant (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Hormonal Agents, Suppressant (Pituitary)
              Pegvisomant
               D05394  Pegvisomant (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D05394  Pegvisomant (USAN/INN); Pegvisomant (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                GHR
                 D05394  Pegvisomant (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05394
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05394
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05394
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05394
DBLINKS     CAS: 218620-50-9
            PubChem: 47207070
            NIKKAJI: J2.535.243B
///
